You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

FDA Panel to Review Pfizer’s Application for COVID Vaccines for Children

HeadlineOct 26, 2021

Moderna said Monday that two smaller-sized doses of its COVID-19 vaccine produced a powerful immune response in children enrolled in a clinical trial and proved to be safe for people as young as 6 years old. Moderna hasn’t yet publicly released its data, and the results are not yet peer reviewed.

Today an FDA advisory committee meets to review Pfizer’s application for emergency use of its COVID vaccine for U.S. children aged 5 to 11. Final approval from the CDC could come as soon as next week. The American Academy of Pediatrics reports about a quarter of all COVID-19 cases over the last week were among children, with over 118,000 infections. 

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top